Shilpa Medicare Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Press Release".
Press Release Feb 24 2026
Earlier from Shilpa Medicare
- Press Release Jan 28 2026
- Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices
- Shilpa Medicare Announces Positive Phase 3 Results for OERIS™ -- A Novel Once-Weekly Ondansetron Extended-Release Injection for Chemotherapy-Induced Nausea and Vomiting (CINV)
- Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide